Published in Cancer Lett on December 16, 2008
Lymphocytes in cancer development: polarization towards pro-tumor immunity. Cytokine Growth Factor Rev (2009) 1.68
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. J Clin Invest (2015) 1.51
Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy. Mol Cancer (2011) 1.10
In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatment. Int J Mol Sci (2015) 0.92
Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A (2014) 0.91
Autoreactive-Aβ antibodies promote APP β-secretase processing. J Neurochem (2012) 0.89
Immunogenic cell death: can it be exploited in PhotoDynamic Therapy for cancer? Biomed Res Int (2012) 0.87
Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers. J Clin Exp Ophthalmol (2013) 0.86
Serologic laboratory findings in malignancy. Rheum Dis Clin North Am (2011) 0.83
Calreticulin is a B cell molecular target in some gastrointestinal malignancies. Clin Exp Immunol (2009) 0.83
Ribosomal versus non-ribosomal cellular antigens: factors determining efficiency of indirect presentation to CD4+ T cells. Immunology (2010) 0.81
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients. J Transl Med (2015) 0.81
Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Cancer Immunol Immunother (2010) 0.81
TAA polyepitope DNA-based vaccines: a potential tool for cancer therapy. J Biomed Biotechnol (2010) 0.79
Prognostic and diagnostic value of spontaneous tumor-related antibodies. Clin Dev Immunol (2010) 0.78
Autoantibodies to mesothelin in infertility. Cancer Epidemiol Biomarkers Prev (2011) 0.78
Parallel Aspects of the Microenvironment in Cancer and Autoimmune Disease. Mediators Inflamm (2016) 0.78
Correlation between centromere protein-F autoantibodies and cancer analyzed by enzyme-linked immunosorbent assay. Mol Cancer (2013) 0.78
Coherent somatic mutation in autoimmune disease. PLoS One (2014) 0.78
Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation. Sci Rep (2016) 0.76
Anti-HE4 antibodies in infertile women and women with ovarian cancer. Gynecol Oncol (2013) 0.76
Anti-MTOC-MT antibody is commonly detected by AIT test in colorectal cancer patients. Virchows Arch (2009) 0.75
Autoimmunity and tumor immunology: two facets of a probabilistic immune system. BMC Syst Biol (2014) 0.75
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients. PLoS One (2016) 0.75
In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway. Proc Natl Acad Sci U S A (2016) 0.75
Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients. PLoS One (2017) 0.75
Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO J (1995) 3.48
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood (2001) 2.92
Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
Wisconsin Card Sorting Test performance in patients with focal frontal and posterior brain damage: effects of lesion location and test structure on separable cognitive processes. Neuropsychologia (2000) 2.03
Crystal structure of the Xrcc4 DNA repair protein and implications for end joining. EMBO J (2000) 1.94
Immunosenescence and infectious diseases. Microbes Infect (2001) 1.71
The effects of focal anterior and posterior brain lesions on verbal fluency. J Int Neuropsychol Soc (1998) 1.59
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J (1998) 1.50
Establishment and characterization of a human neuroblastoma cell line. Int J Cancer (1989) 1.43
Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Cancer Res (1992) 1.39
DNA-binding and strand-annealing activities of human Mre11: implications for its roles in DNA double-strand break repair pathways. Nucleic Acids Res (2001) 1.38
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. Lab Invest (1999) 1.37
Group B streptococci persist inside macrophages. Immunology (1998) 1.36
Broca's area aphasias: aphasia after lesions including the frontal operculum. Neurology (1990) 1.33
Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst (1997) 1.30
Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci U S A (1982) 1.21
Optociliary veins and central retinal vein occlusion. Br J Ophthalmol (1993) 1.16
Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immunol (1992) 1.15
Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Int J Cancer (1993) 1.15
A three-dimensional ultrastructural study of osteoid-osteocytes in the tibia of chick embryos. Cell Tissue Res (1986) 1.12
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia. Science (1987) 1.10
Cardiac growth factors in human hypertrophy. Relations with myocardial contractility and wall stress. Circ Res (1999) 1.08
IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci (1995) 1.08
Inactivation of the IL-6 gene prevents development of multicentric Castleman's disease in C/EBP beta-deficient mice. J Exp Med (1996) 1.08
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J Immunol (2000) 1.08
Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity. J Immunol (1987) 1.07
Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ (1991) 1.05
Suppression of src-induced transformed phenotype by expression of tropomyosin-1. Oncogene (1999) 1.05
Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus. J Virol (2008) 1.04
Quantitative evaluation on osteocyte canalicular density in human secondary osteons. Bone (1995) 1.02
Low doses of IL-4 injected perilymphatically in tumor-bearing mice inhibit the growth of poorly and apparently nonimmunogenic tumors and induce a tumor-specific immune memory. J Immunol (1990) 1.02
Neuropsychological and neuroanatomical dimensions of ideomotor apraxia. Brain (1992) 1.01
Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall Med (2007) 1.01
Type V collagen in human amnion is a 12 nm fibrillar component of the pericellular interstitium. Eur J Cell Biol (1984) 1.01
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. J Immunol (1999) 1.01
Central retinal vein occlusion in young people. Doc Ophthalmol (1992) 1.00
Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation. Leukemia (2012) 1.00
Heterozygote detection in cystinosis, using leukocytes exposed to cystine dimethyl ester. N Engl J Med (1982) 0.99
Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest (1996) 0.99
Cytokines, tumour-cell death and immunogenicity: a question of choice. Immunol Today (1997) 0.98
Death of bystander cells by a novel pathway involving early mitochondrial damage in human immunodeficiency virus-related lymphadenopathy. Blood (1997) 0.97
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4. J Immunol (1994) 0.95
5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J Immunol (1995) 0.95
The Ras suppressor RSU-1 localizes to 10p13 and its expression in the U251 glioblastoma cell line correlates with a decrease in growth rate and tumorigenic potential. Oncogene (1995) 0.95
Looking for residues involved in the muscle acylphosphatase catalytic mechanism and structural stabilization: role of Asn41, Thr42, and Thr46. Biochemistry (1996) 0.94
A quantitative evaluation of osteoblast-osteocyte relationships on growing endosteal surface of rabbit tibiae. Bone (1992) 0.93
Immune responses to all ErbB family receptors detectable in serum of cancer patients. Oncogene (1999) 0.91
Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res (1993) 0.91
Comparative diagnostic evaluation with MR cholangiopancreatography, ultrasonography and CT in patients with pancreatobiliary disease. Radiol Med (2009) 0.90
Increased TGFbeta type II receptor expression suppresses the malignant phenotype and induces differentiation of human neuroblastoma cells. Exp Cell Res (2000) 0.90
Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma. Exp Cell Res (1996) 0.90
V(D)J recombination: links to transposition and double-strand break repair. Cold Spring Harb Symp Quant Biol (1999) 0.90
Histomorphometric study on the osteocyte lacuno-canalicular network in animals of different species. I. Woven-fibered and parallel-fibered bones. Ital J Anat Embryol (1999) 0.90
In vivo leptin expression in cartilage and bone cells of growing rats and adult humans. J Anat (2004) 0.89
Neutrophils in anti-cancer immunological strategies: old players in new games. J Hematother Stem Cell Res (2001) 0.89
Arginine-23 is involved in the catalytic site of muscle acylphosphatase. Biochim Biophys Acta (1994) 0.89
Some clinical considerations regarding the relation of coronary vasospasm to coronary atherosclerosis: a hypothetical pathogenesis. Am J Cardiol (1980) 0.88
Different carbon sources affect lifespan and protein redox state during Saccharomyces cerevisiae chronological ageing. Cell Mol Life Sci (2009) 0.88
Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice. J Biol Regul Homeost Agents (2013) 0.88
An ultrastructural study of recurrent disc herniation: a preliminary report. Spine (Phila Pa 1976) (1983) 0.88
Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis. Am J Hematol (2001) 0.87
Neuromodulatory loop mediated by nerve growth factor and interleukin 6 in thymic stromal cell cultures. Proc Natl Acad Sci U S A (1992) 0.85
Heavy metal toxicity following apical and basolateral exposure in the human intestinal cell line Caco-2. Toxicol In Vitro (1996) 0.85
A new acylphosphatase isoenzyme from human erythrocytes: purification, characterization, and primary structure. Biochemistry (1986) 0.84
HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt. Eur J Epidemiol (1999) 0.84
Histomorphometric study on the osteocyte lacuno-canalicular network in animals of different species. II. Parallel-fibered and lamellar bones. Ital J Anat Embryol (1999) 0.84
[Bone marrow changes in HIV-positive patients (clinical, cytological, histological, and ultrastructural study of 57 cases)]. Pathologica (1997) 0.84
Immunophenotypical changes of T lymphocytes in the elderly. Gerontology (2000) 0.84
Multiplex PCR analysis and genotype-phenotype correlations of frequent APC mutations. Hum Mutat (1995) 0.84
The mechanism of transduction of mechanical strains into biological signals at the bone cellular level. Eur J Histochem (2007) 0.83
Intermittent compressive load stimulates osteogenesis and improves osteocyte viability in bones cultured "in vitro". Clin Rheumatol (1996) 0.83
Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. J Biol Regul Homeost Agents (2012) 0.83
Bone as an ion exchange system: evidence for a link between mechanotransduction and metabolic needs. Am J Physiol Endocrinol Metab (2002) 0.82
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. Int J Immunopathol Pharmacol (2004) 0.82
Rat Leydig cells bind platelet-derived growth factor through specific receptors and produce platelet-derived growth factor-like molecules. Endocrinology (1992) 0.82
The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases. Clin Exp Allergy (1999) 0.81
Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage. Virchows Arch A Pathol Anat Histopathol (1988) 0.81
Different skeletal regional response to continuous brain infusion of leptin in the rat. Peptides (2006) 0.81
Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines. Gene Ther (1997) 0.81
Expression and synthesis of fibronectin and laminin by an intestinal epithelial cell line. Tissue Cell (1988) 0.81
Effect of chronic hyperoxia on young and old rat carotid body ultrastructure. Exp Gerontol (1998) 0.81
Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3. Biochem Mol Biol Int (1997) 0.81
Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.81
A novel mutation at the splice junction of exon 9 of the APC gene in familial adenomatous polyposis. Hum Mutat (1994) 0.80
Modulation of fibronectin and thymic stromal cell-dependent thymocyte maturation by retinoic acid. J Immunol (1994) 0.80
SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma. Dev Biol Stand (1998) 0.80
Type I consensus IFN (IFN-con1) gene transfer into KSHV/HHV-8-infected BCBL-1 cells causes inhibition of viral lytic cycle activation via induction of apoptosis and abrogates tumorigenicity in sCID mice. J Interferon Cytokine Res (1999) 0.80
The use of a cationic liposome formulation (DOTAP) mixed with a recombinant tumor-associated antigen to induce immune responses and protective immunity in mice. J Immunother (1998) 0.80
Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci (2000) 0.80
Rat natural killer cells synthesize fibronectin. Possible involvement in the cytotoxic function. J Immunol (1989) 0.80